A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
Conditions: Seasonal Allergic Conjunctivitis Interventions: Drug: Epinastine Hcl Oph Soln+Simulating Azelastine Hcl Oph Soln; Drug: Azelastine Hcl Oph Sol+Simulating Epinastine Hcl Oph Soln Sponsors: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
BIOEQUIVALENCE STUDY OF AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE 137 Microgram/50 Microgram NASAL SPRAY AND'DYMISTA' (AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE) NASAL SPRAY 137 Microgram/50 Microgram
Conditions: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis Interventions: Drug: Azelastine Hydrochloride/ Fluticasone propionate nasal spray; Drug: ' DYMISTA ' NASAL SPRAY Sponsors: Humanis Sagl ık Anonim Sirketi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Azelastine Allergen Chamber - Onset of Action Study
Conditions: Seasonal Allergic Rhinitis Interventions: Drug: Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair); Drug: Treatment B: Placebo (Azelastine 0.15% vehicle) nasal spray; Drug: Treatment C: Ryaltris (Active Control) - mometasone furoate monohydrate and olopatadine hydrochloride nasal spray Sponsors: MEDA Pharma GmbH& Co. KG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Condition: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsor: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Conditions: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista ™ Sponsors: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Pilot Clinical Evaluation of Astepro ® Nasal Spray for Management of Early SARS-CoV-2 Infection
Condition: COVID-19 Interventions: Drug: Experimental: Primary Cohort; Other: Placebo Comparator: Primary Cohort - Placebo Sponsor: University of Chicago Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials
